chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was vaccinated 09/07/1995. It was noted that the patient has a history of recent varicella exposure from his sister 10 days prior. On 09/12/2000 the patient complained of a sore on the right buttock which was the size of a nickel and looked like a popped blister. It was reported the patient developed a few more blisters looking more like zoster in the local area over the next few days. All the lesions were localized to the buttock and were sore to the touch. Unspecified medical attention was sought and the patient received 10-14 days total treatment.  The patient's sister experienced a reaction following exposure to varicella virus vaccine live. Additionally, it was noted that the physician felt that the results were "interesting" since the two siblings had broken out within 2 weeks of each other. He stated that he "guessed it could have been a herpes simplex". Follow up information from a physician indicated that there was 1 6 x 4 inch area of papules and vesicles which was located on the right gluteal region. The patient's pain was noted to be 1 on a 1-10 scale. There were no other systemic symptoms and the patient was afebrile. Additionally, it was noted that a rash did not occur at the site of the injection or elsewhere within 42 days of the vaccination. The patient was treated acyclovir and recovered 09/20/2000. No further information is available.
4 days after receiving vaccine started with fever to 101 and lymphadenopathy to right inguinal node 2cm. Instructed parent to monitor for changes.
Info has been received from a physician concerning her son, a 19 month old male, who in October 2005, was vaccinated, SC, with an 0.5 mL dose of MMRII. Concomitant vaccination that day included a dose of poliovirus vaccine and a dose of DPT. Four days after vaccination, in October 2005, the pt developed a fever of 102F. On the fifth day he developed a measles rash that lasted about 4 days and than resolved on it's own. The child was irritable over this time period, unspecified medical attention was sought. No treatment was given. No lab/diagnostic tests were performed. The pt recovered. There was no product quality complaint involved. Additional info has been requested.
Post menopausal vaginal bleeding.    Minor immediate reactions after 1st shot is a funny metallic taste in my mouth that hasn't gone away and a funny smell in my nose reducing my sense of smell.
said he had lots of swelling/ redness. his arm was large. it happened gradually over a few days and then went to ER after it got a lot worse. was given steroid at hospital and recovered. has no symptoms now.
no adverse event; patient was administered a dose of expired V ARIV AX; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided.  On 16-JUL-2020, the patient was vaccinated with  a dose of properly stored but expired varicella virus vaccine live (oka/merck)(VARIVAX) lot # R013566, expiration date 13-MAY-2020, subcutaneously (vaccination site was not reported), for prophylaxis which was reconstituted with properly stored and non expired sterile diluent.
Pt started to Feel tired on 07/17/2020 in evening. Then inside of arm (right) From arm pit to elbow had swelling, redness, and hot to touch. He reported fever of 100 degrees and was controlled with aspirin. Swelling and edema started to reduce on Sunday. He said the reaction was completely resolved on Tuesday.
Pt received first dose of the Pfizer covid19 vaccine at 1014.  Immediately after pt stated feeling anxious, dizzy and  like her heart was pounding.  Pt was monitored, provided water and was released at 1140 after symptoms went away.
Started with high fever on Sat (101), extreme weakness on Sunday, Monday and Tuesday.  Went back to work on Wednesday, still not feeling but felt I should be trying to do something by then.  Drove to work (35 min from my home), parked my car and that is the last thing I recall for approx 2 hours.  Had grand mal seizure 1 hour later   that lasted 2-3 minutes.  Also found to have UTI that had no symptoms of as well severe in nature.
Developed rash over body, primarily concentrated in groin and armpits, but distributed throughout body except for face. Tried over the counter benadryl pills and cream with no success.  Got progressively worse over the next 3 days.  Had for four days before going to urgent care.  Other causes (food, new soap, lotions, etc.) were ruled out. Diagnosed as: Systemic acute urticaria of unknown origin Was given benadryl shot and prescription for a 5 day course of prednisone. Was recommended to take anti-histamine in the morning and continue with benadryl cream; Aveeno oatmeal baths, if needed. Was given a referral to dermatology.  One day post doctor's visit, no visible relief of symptoms.
The patient developed a maculopapular rash over the entire trunk.  Unclear if caused by this vaccine or Shingles vaccine which patient received first in series for on the same day.
BLURRED VISION; This spontaneous report received from a patient  concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient was previously treated with Tylenol (paracetamol) for loss of mobility in arm which caused by pneumococcal vaccine. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On APR-2021, the subject experienced blurred vision. The action taken with covid-19 vaccine  was not applicable. The outcome of blurred vision was not reported. This report was non-serious.
Some time after receiving the shot (not sure of the date), I developed pain in my arm and shoulder such that I could not raise my arm above my shoulder. I thought it was a torn rotator cuff. Because of my age and the adverse experience of some of my friends with rotator cuff surgery, I elected not to go to the doctor with it. The pain was constant and ranged from a 2 to a 9. I could not sleep on the affected arm and had to use extra covers on it at night to keep it warm and minimize the pain. I suffered with it 8 months. Then, in June 2022, I caught covid. On the third day of the virus, I noticed my pain getter better and better. The strange thing is that now the arm problem has gone away. I can raise my arm over my head. while there is some minimal residual pain, the mobility problem is gone. I did receive Paxlovid from my physician on the fourth day of my covid illness, and that may have been a factor.
Pt went limp and unresponsive for about 30-40 seconds immediately following 2nd Gardasil vaccination.
pt recv vax 31MAR97 & it was reported that 2 days post vax pt broke out in a rash that covered pt entire body & then pt had difficulty breathing;pt was hosp & treated w/DPH, cortisone & oral steroid pack;
Headache; Chills; Temperatures; runny nose; sore throat; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN), via unspecified route of administration in the left arm on 03Mar2021 at 15:30 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Medical history and allergies to medications, food, or other products was reported as yes. The patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 03Mar2021 at 21:00, the patient experienced headache, chills, temperatures, runny nose and sore throat. The patient did not receive any treatment for the events. The clinical outcome of the events headache, chills, temperatures, runny nose and sore throat was recovered on unknown date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Extreme fatigue; This is a spontaneous report from a contactable consumer. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an intramuscular route of administration in the left arm on 29May2021 at 14:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation.  Medical history was not reported. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and ibuprofen (MANUFACTURER UNKNOWN) for unknown indications from an unknown date. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29May2021 at 20:00, the patient had experienced extreme fatigue. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event extreme fatigue was recovered on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
LOSS OF CONSCIOUSNESS FOR 18 HOURS. HOSPITALIZED FOR LACK OF ABILITY TO COMMUNICATE AND MOVE.
Headache, Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, chills, fatigue and swollen glands, pain at injection site Narrative:
a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021); Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatments were provided. HCP has provided demographics for all the patients who received a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021). For this patient, the number of days that have passed were 9.   This case was linked to MOD-2021-278394 (Patient Link).
He had bad side effects of the vaccine; This is a spontaneous report from a non-contactable consumer or other non hcp from a Pfizer-sponsored program. A male patient of an unspecified age received first dose of BNT162B2 (Pfizer COVID-19 Vaccine, formulation: solution for injection, batch/Lot number was not reported), via an unspecified route of administration on Apr2021 as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he got the first dose of the Pfizer vaccine a month ago (Apr2021), and he mentioned that he had bad side effects of the vaccine. The patient was not able to specify what the side effects were. The outcome of the event was unknown.  Medical Information: No customer and/or medical inquiry was not forwarded or referred to MI.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023; No adverse event; Expired vaccine that was administered on 15-March-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered on 15-March-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered on 15-March-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered on 15-March-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered on 15-March-2023) and PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023).    No concomitant medications were reported.  Vial size was reported as 10 dose vial. The vial was initially stored in the refrigerator on 14-MAR-2023  The vial did not undergo any temperature excursions. It was reported that HCP stated the expired Moderna COVID-19 monovalent vaccine was administered to approximately 75-125 patients on 15-MAR-2023. There was potentially a second lot number that was expired and was administered to patients on 3-MAR-2023, but HCP did not have any details on this event at this time. The second potential lot was confirmed to not be used. There are a total of 82 patients involved. HCP wants to know if the vaccine administered on 15-MAR-2023 would be considered valid for the patients.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master Case
Shoulder pain, limited movement in all joints, back pain, neck pain. Have several diseases; doctors can not yet tell if from the vaccine. Per follow-up information: Have fibromyalgia, have joint pain all over, need surgery now. The 60 day follow-up states," I don't think I ever will."  Annual follow up on 07/31/2003: "Patient is unknown about the recovery of adverse events.  Patient still having a lot of problems."
Parents reports 2hours after receiving vaccines that child reported rt. arm was "itchy". This resolved after 1/2 hour. Parent denies any redness or warmth or swelling of the site. No other adverse events reported.
pt recv vax 4DEC93 & 13SEP97 pt exp hair loss;reporter noted that parents reports every time pt recv vax pt exp hair loss;parents felt the hair loss was r/t MMR vax;
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 22Apr2021 as dose 1, single (Lot number: EW0170), on 13May2021 as dose 2, single (Lot number: EV0179) and on 26Nov2021 as dose 3 (booster), single (Lot number: PH8020), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypohidrotic epidermal dysplasia" (unspecified if ongoing); "frequent bronchitis or pneumonia" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Ciprofloxacin, reaction(s): "Allergy: Ciprofloxacin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
PATIENT WAS FINE AFTER THE VACCINATION, STOOD UP WALKED AROUND THE STORE FOR A FEW MINUTES AND CAME BACK WITH FACE AND ARMS FLUSHED RED. PATIENT ALSO REPORTED CHEST PAIN AND DIFFICULTY BREATHING. AFTER LOWERING PATIENT TO SEATING POSITION SHE REPORTED SEVERE SHARP PAIN IN LOWER BACK AREA. I INSTRUCTED PATIENT TO TAKE DEEP BREATHS (WHILE HAVING EPIPEN READY AND AMBULANCE WAS CALLED AT THIS POINT) PATIENT PALOR RETURNED TO A MORE NORMAL COMPLEXION BEFORE PARAMEDICS ARRIVED AND THE CHEST PAIN AND BREATHING WAS ALSO RESOLVED BUT THE SHARP LOWER BACK PAIN REMAINED . PATIENT WAS TAKING BY PARAMEDICS TO EMERGENCY CENTER WHERE AN EKG WAS COLLECTED. PATIENT LATER CALLED THE PHARMACY AND REPORTED THAT INITIALLY THERE WAS NAUSEA AS WELL FOR WHICH SHE WAS PRESCRIBED MEDICINE (NAME NOT PROVIDED). SHE ALSO REPORTS NO OTHER SYMPTOMS AND EVERYTHING WAS RESOLVED WITHIN HOURS OF ADMINISTRATION
In February, 99, the pt received her first injection of Lymerix. (She had spent 6 months in a high tick area.) She received her second injection in August, 99, and the third injection in February, 2000. About 2-3 months ago, the pt experienced achiness in her rib (where old fracture was). The achiness occurs while either sitting or lying down. The most recent information received on 3/15/00 reports the outcome of the achiness as ongoing.
Chills; Headache; Joint aches; Tired; Nausea; This is a spontaneous report from a contactable non healthcare professional, the patient. A 52-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 26Apr2021 at 11:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included barrett's esophagus. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN); all from unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Apr2021 at 09:00,  the patient experienced chills, headache, joint aches, tired, nausea. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills, headache, joint aches, tired, nausea. was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Three swollen lymph nodes in armpit that do have not subside d/gotten smaller over the past 8 months. Mammogram and other tests show no other underlying disease
tingle in lips; dry mouth; swallowing differences; slight fever; headaches; tried; muscle aches; This is a spontaneous report from a contactable consumer (patient). A 65 Years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6203), via an unspecified route of administration in left arm on 28Feb2021 at 10:00 AM at single dose for COVID-19 immunisation. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: (ID) 9809), via an unspecified route of administration in left arm on 07Feb2021 at 10:00 AM at single dose for COVID-19 immunisation and experienced head rush immediately after injection, extremely sore arm from first dose. Medical history included COVID 19 and allergic to flagyl, ciprofloxacin. The patient did not received other vaccine in four weeks. The patient did not tested for covid tested post vaccination. Concomitant medications included amlodipine besilate at 2.5 mg, metformin hydrochloride (METFORMIN ER) at 500 mg. On 28Feb2021 at 10:15 PM, the patient experienced tingle in lips, dry mouth, swallowing differences, slight fever, headaches, tried, muscle aches. No treatment was received. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
trying to burp pt upper body started vibrating (jerking) x 5 sec hands & feet went white; no LOC;
3 minutes after received vaccine, wheezing was reported and she passed out. Would not come to despite lowering to floor, lifting legs, stimulation. EPI-PEN given, she immediately woke up. Transferred to ED, Did EKG's which were (-). Diagnosed with syncope episode.
This spontaneous report as received from a medical assistant refers to a 17 months old patient of unknown gender. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date, the patient was administered a dose of PROQUAD (dosing details were not reported) at age 1, and was given a second dose at age 17 months (lot numbers and expiration dates were not available to the reporter) for prophylaxis. No adverse effects were reported in the patient. No product quality complaint involved.
There was an excursion from the freezer,vaccine administered to 118 patients; There was an excursion from the freezer,vaccine administered to 118 patients; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer,vaccine administered to 118 patients) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from the freezer,vaccine administered to 118 patients) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer,vaccine administered to 118 patients) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from the freezer,vaccine administered to 118 patients). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer,vaccine administered to 118 patients) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from the freezer,vaccine administered to 118 patients) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not reported. Treatment medications was not reported